BioXcel Therapeutics Inc. (BTAI) SEC News Oct. 30, 2025, 11:15 UTC 3 1 comments (80% Positive) BioXcel Therapeutics, Inc. (BTAI) Announces Clinical Development Update Comment Full text
Cartesian Therapeutics Inc (RNAC) SEC News Oct. 30, 2025, 11:10 UTC 3 1 comments (10% Negative) CARTESIAN THERAPEUTICS, INC. (RNAC) Announces Delay in instrumental Trials for autoimmune diseases Due to Geopolitical Situation, Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review Comment Full text
Bristol-Myers Squibb Company (BMY) SEC News Oct. 30, 2025, 11:09 UTC 3 1 comments (10% Negative) BRISTOL-MYERS SQUIBB COMPANY (BMY) Reports Q4 2025 Financial Results Comment Full text
Bicycle Therapeutics (BCYC) SEC News Oct. 30, 2025, 11:05 UTC 3 1 comments (30% Negative) Bicycle Therapeutics plc (BCYC) Reports Q4 2025 Financial Results Comment Full text
Eli Lilly and Company (LLY) SEC News Oct. 30, 2025, 11:03 UTC 3 1 comments (90% Positive) ELI LILLY AND COMPANY (LLY) Reports Q4 2025 Financial Results Comment Full text
HALEON PLC (HLN) SEC News Oct. 30, 2025, 11:01 UTC 3 1 comments (99% Neutral) HALEON PLC (HLN) Files Form 6-K Comment Full text
Liquidia Corporation (LQDA) SEC News Oct. 30, 2025, 11:00 UTC 3 1 comments (99% Neutral) LIQUIDIA CORPORATION (LQDA) Announces Business Combination Comment Full text
Insmed Inc (INSM) SEC News Oct. 30, 2025, 11:00 UTC 1 1 comments (10% Negative) INSMED INCORPORATED (INSM) Reports Q4 2025 Financial Results Comment Full text
Phathom Pharmaceuticals Inc (PHAT) SEC News Oct. 30, 2025, 11:00 UTC 1 1 comments (30% Negative) PHATHOM PHARMACEUTICALS, INC. (PHAT) Reports Q4 2025 Financial Results Comment Full text
Novocure Ltd (NVCR) SEC News Oct. 30, 2025, 10:59 UTC 3 1 comments (30% Negative) NovoCure Limited (NVCR) Reports Q4 2025 Financial Results Comment Full text